Study Title
A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects (OPTIMUM)
Study Details
Description:
The purpose of this study is to evaluate the efficacy and safety of 131I-MIBG in combination with Vorinostat in patients with Recurrent or Progressive neuroblastoma
Sponsor:
Jubilant Radiopharma
Government Study Link:
NCT03561259 - Click here to see study onClinicalTrials.gov